
### [NCIT:C7596](http://purl.obolibrary.org/obo/NCIT_C7596)
**Label:** Malignant Myoepithelioma

**Subclasses:** [NCIT:C121787](http://purl.obolibrary.org/obo/NCIT_C121787) (Malignant Mixed Tumor, Not Otherwise Specified), [NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma), [NCIT:C35700](http://purl.obolibrary.org/obo/NCIT_C35700) (Salivary Gland Myoepithelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 51.82%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 45.36%
- [NCIT:C48898](http://purl.obolibrary.org/obo/NCIT_C48898) (Painless Mass) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 45.36%


